Total voting rights
2010年9月30日 - 9:27PM
RNSを含む英国規制内ニュース (英語)
TIDMRGT
Immediate Release
30 September 2010
ReGen Therapeutics Plc
("ReGen" or the "Company")
Total Voting Rights
For the purposes of the Disclosure and Transparency Rules of the Financial
Services Authority, the Board of ReGen is required to notify the market of the
following:
As at the date of this announcement, the Company's issued share capital consists
of 78,446,584 ordinary shares with a nominal value of 0.01 p each, with voting
rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in
Treasury.
Therefore the total number of Ordinary Shares in the Company with voting rights
is 78,446,584.
The above figure of 78,446,584 Ordinary Shares may be used by shareholders in
the Company as the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to their interest
in, the share capital of the Company under the Financial Service Authority's
Disclosure and Transparency Rules.
ENDS
For further information:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
[HUG#1448016]
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: ReGen Therapeutics Plc via Thomson Reuters ONE
Argent Biopharma (LSE:RGT)
過去 株価チャート
から 8 2024 まで 9 2024
Argent Biopharma (LSE:RGT)
過去 株価チャート
から 9 2023 まで 9 2024